These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 19201691)

  • 21. PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury.
    Yang HM; Kim BK; Kim JY; Kwon YW; Jin S; Lee JE; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
    Exp Mol Med; 2013 Nov; 45(11):e65. PubMed ID: 24287871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of the Ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia.
    Dong LH; Wen JK; Liu G; McNutt MA; Miao SB; Gao R; Zheng B; Zhang H; Han M
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):683-91. PubMed ID: 20139360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.
    Kim HJ; Yoo EK; Kim JY; Choi YK; Lee HJ; Kim JK; Jeoung NH; Lee KU; Park IS; Min BH; Park KG; Lee CH; Aronow BJ; Sata M; Lee IK
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1558-64. PubMed ID: 19696405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of 2,3,4',5-tetrahydroxystilbene-2-0-β-D glucoside on neointima formation in a rat artery balloon injury model and its possible mechanisms.
    Xu XL; Ling DY; Zhu QY; Fan WJ; Zhang W
    Eur J Pharmacol; 2013 Jan; 698(1-3):370-8. PubMed ID: 23178522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling.
    Yang HM; Kim HS; Park KW; You HJ; Jeon SI; Youn SW; Kim SH; Oh BH; Lee MM; Park YB; Walsh K
    Circulation; 2004 Jul; 110(3):301-8. PubMed ID: 15238462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
    Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
    PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. l-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty.
    Yokouchi K; Numaguchi Y; Kubota R; Ishii M; Imai H; Murakami R; Ogawa Y; Kondo T; Okumura K; Ingber DE; Murohara T
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2231-7. PubMed ID: 16888241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of Cavin-1 Expression via Increasing Caveolin-1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury-Induced Neointimal Hyperplasia.
    Zhou LJ; Chen XY; Liu SP; Zhang LL; Xu YN; Mu PW; Geng DF; Tan Z
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury.
    Yan G; Wang Q; Hu S; Wang D; Qiao Y; Ma G; Tang C; Gu Y
    Int J Mol Med; 2015 Oct; 36(4):1001-11. PubMed ID: 26311435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of angiotensin II type 2 receptor suppresses neointimal hyperplasia in a rat carotid arterial balloon injury model.
    Tang B; Ma S; Yang Y; Yang D; Chen J; Su X; Tan Y; Sun M; Li D
    Mol Med Rep; 2011; 4(2):249-54. PubMed ID: 21468559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
    Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
    Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Efficacy of Systemic Doxycycline Administration as an Inhibitor of Intimal Hyperplasia after Balloon Angioplasty Arterial Injury.
    Mountain DJH; Kirkpatrick SS; Arnold JD; Buckley MR; McNally MM; Stevens SL; Freeman MB; Grandas OH
    Ann Vasc Surg; 2019 May; 57():201-209. PubMed ID: 30684618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indole-3-carbinol blocks platelet-derived growth factor-stimulated vascular smooth muscle cell function and reduces neointima formation in vivo.
    Guan H; Chen C; Zhu L; Cui C; Guo Y; Fu M; Wang L; Tang Q
    J Nutr Biochem; 2013 Jan; 24(1):62-9. PubMed ID: 22784431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
    Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia.
    Aizawa Y; Kawabe J; Hasebe N; Takehara N; Kikuchi K
    Circulation; 2001 Jul; 104(4):455-60. PubMed ID: 11468209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrogallol abates VSMC migration via modulation of Caveolin-1, matrix metalloproteinase and intima hyperplasia in carotid ligation mouse.
    Ma YD; Thiyagarajan V; Tsai MJ; Lue SI; Chia YC; Shyue SK; Weng CF
    Environ Toxicol Pharmacol; 2016 Dec; 48():63-75. PubMed ID: 27768988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.
    Wu H; Cheng XW; Hu L; Takeshita K; Hu C; Du Q; Li X; Zhu E; Huang Z; Yisireyili M; Zhao G; Piao L; Inoue A; Jiang H; Lei Y; Zhang X; Liu S; Dai Q; Kuzuya M; Shi GP; Murohara T
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1549-57. PubMed ID: 27365406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycogen synthase kinase-3beta is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts.
    Kandasamy AD; Schulz R
    Cardiovasc Res; 2009 Sep; 83(4):698-706. PubMed ID: 19493954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human interleukin-10 inhibits proliferation of vascular smooth muscle cells stimulated by advanced glycation end products and neointima hyperplasia after carotid injury in the rat.
    Ouyang P; Peng LS; Yang H; Peng WL; Wu WY; Xu AL
    Sheng Li Xue Bao; 2003 Apr; 55(2):128-34. PubMed ID: 12715099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.